Lurie Cancer Center and Northwestern Medicine Experts to Present at the 2025 AACR Annual Meeting
Physicians and scientists from the Robert H. Lurie Comprehensive Cancer Center of Northwestern University and Northwestern Medicine will share and discuss leading-edge research at the 2025 American Association for Cancer Research Annual Meeting, April 25–30 in Chicago.
The meeting theme, “Unifying Cancer Science and Medicine: A Continuum of Innovation for Impact,” reflects the critical importance of advancing cancer research from the bench to the clinic and back to the bench.
Use #AACR25 to share insights from the meeting. Follow and tag:
@LurieCancer on X and @LurieCancer.bsky.social on Bluesky
@Northwestern Med on X
Some of our notable presentations and sessions are listed below. For a full list of presentations, visit the AACR website
Saturday, April 26
Bridging the Gap: Ensuring a Broad Representation of Patients in Cancer Clinical Trials
Dario Roque, MD – Invited Speaker
Somatic mosaicism as a driver of hematopoietic malignancies and inflammatory diseases
Lucy Godley, MD – Chair and Presenter
Chemistry to the Clinic Part 3 of 3: Advances in Ligand Discovery to Enable Previously Intractable Targets
Discovery of small molecule-mediated protein degradation pathways
Xiaoyu Zhang, PhD – Presenter
Sunday, April 27
Major Symposium- Mitochondrial Biology in Cancer
Navdeep Chandel, PhD -- Chair
Monday, April 28
Critical Dependencies in Hematologic Malignancies: A Hematologic Malignancies Working Group Town Hall
Lucy Godley, MD – Speaker
Tuesday, April 29
Clinical Trials Plenary Session – Biologics and T-cell Engagers
ICAM-1 directed chimeric antigen receptor (CAR) T cells (AIC100) in patients with advanced thyroid cancers: Clinical and translational data from the phase 1 dose escalation study
Jochen Lorch, MD, and Adam Lin, MD, PhD – Co-Authors
Phase II Clinical Trials
Phase II open-label multi-cohort study evaluating CPI-613 (devimistat) in combination with hydroxychloroquine and 5-fluorouracil or gemcitabine in patients with advanced chemo-refractory solid tumors
Carolyn Moloney, MD – Presenter
Wednesday, April 30
Late-Breaking Research: Clinical Research 4
Trop-2 expression and association with efficacy in patients treated with sacituzumab govitecan + pembrolizumab +/- carboplatin in the EVOKE-02 study of non-small cell lung cancer
Jyoti Patel, MD -- Presenter